SYRE logo

SYRE
Aeglea BioTherapeutics Inc

2,063
Mkt Cap
$3.72B
Volume
712,520.00
52W High
$49.31
52W Low
$10.91
PE Ratio
-22.77
SYRE Fundamentals
Price
$45.42
Prev Close
$47.31
Open
$47.75
50D MA
$38.47
Beta
1.68
Avg. Volume
771,183.17
EPS (Annual)
-$1.98
P/B
6.61
Rev/Employee
$0.00
$1,497.78
Loading...
Loading...
News
all
press releases
Spyre Therapeutics (NASDAQ:SYRE) Trading Up 5.7% - Time to Buy?
Spyre Therapeutics (NASDAQ:SYRE) Trading 5.7% Higher - Time to Buy...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Spyre Therapeutics (NASDAQ:SYRE) Sets New 12-Month High - Here's What Happened
Spyre Therapeutics (NASDAQ:SYRE) Hits New 52-Week High - Here's Why...
MarketBeat·5d ago
News Placeholder
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Receives Average Rating of "Buy" from Brokerages
Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) have earned an average rating of "Buy" from the ten research firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, seven have given a buy recommendation...
MarketBeat·6d ago
News Placeholder
Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools
Key PointsVR Adviser, LLC added 1,000,000 shares of Spyre Therapeutics; estimated trade size is $25.78 million (based on quarterly average pricing...
Nasdaq News: Markets·12d ago
News Placeholder
Spyre Therapeutics (NASDAQ:SYRE) Price Target Raised to $92.00
Stifel Nicolaus increased their target price on shares of Spyre Therapeutics from $70.00 to $92.00 and gave the company a "buy" rating in a research report on Wednesday...
MarketBeat·12d ago
News Placeholder
Spyre Therapeutics (NASDAQ:SYRE) Trading Up 9.3% - Should You Buy?
Spyre Therapeutics (NASDAQ:SYRE) Trading 9.3% Higher - What's Next...
MarketBeat·14d ago
News Placeholder
Spyre Therapeutics (NASDAQ:SYRE) Given Buy Rating at BTIG Research
BTIG Research reissued a "buy" rating and set a $70.00 target price on shares of Spyre Therapeutics in a report on Monday...
MarketBeat·14d ago
News Placeholder
Spyre Therapeutics, Inc. $SYRE Shares Acquired by HighVista Strategies LLC
HighVista Strategies LLC grew its stake in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) by 91.3% during the 3rd quarter, according to the company in its most recent Form 13F filing...
MarketBeat·14d ago
News Placeholder
Baker BROS. Advisors LP Buys 373,297 Shares of Spyre Therapeutics, Inc. $SYRE
Baker BROS. Advisors LP increased its stake in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) by 59.6% during the third quarter, according to the company in its most recent filing...
MarketBeat·16d ago
News Placeholder
DLD Asset Management LP Acquires New Position in Spyre Therapeutics, Inc. $SYRE
DLD Asset Management LP bought a new position in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The...
MarketBeat·22d ago
<
1
2
...
>

Latest SYRE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.